RTN4 and multiple sclerosis: If the BBB destabilization is needed for IgG and siRNA diffusion into the CNS, it may dramatically limit the duration and effectiveness of intravenously-administered reagents antagonizing Nogo-A in multiple sclerosis, as a sustained delivery seems to be required to keep EAE clinical scores at low levels [10].